Mechanistic and Therapeutic Advances
in Rare Skeletal Diseases
A meeting jointly organized by the Rare Bone Disease Alliance (RBDA), a program of the Osteogenesis Imperfecta Foundation, and the Brittle Bone Disorders Consortium of the NIH Rare Bone Diseases Clinical Research Network, to bring together scientists interested in rare bone disease. The meeting will be held two days prior to the ASBMR 2018 Annual Meeting, Wednesday, September 26 and Thursday, September 27, 2018 in the Palais des congrès de Montréal in Montréal, Québec, Canada. The program will cover state of the art topics in diagnosis, preclinical mechanisms of disease, clinical targeting of signaling pathways and novel clinical endpoints for assessment of efficacy. Visit the Osteogenesis Imperfecta Foundation's website for more information.